Recital 6, Regulation (EU) 2021/2047

In forcesince 23 Nov 2021

The assessment of amprolium hydrochloride (COXAM) shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied. Accordingly, the use of that substance should be authorised.